Is rituximab superior to cyclophosphamide for ANCA-associated vasculitis for induction of remission, and with a better safety profile?

Curr Rheumatol Rep. 2010 Dec;12(6):395-8. doi: 10.1007/s11926-010-0133-y.
No abstract available

Publication types

  • Comment